hotspot -WSS

hotspot

author：entertainment 2025-10-03 00:08:00 - browse：59

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

WSS

FDA panel to weigh approval of NurOwn, controversial ALS drug

Unique patient identifier: Experts argue the benefits, pitfalls

Why Novartis is going to walk from its acquisition of MorphoSys

Cano Health’s bankruptcy is a warning for Medicare Advantage

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

A protest over insulin prices is seen as a fight for life

leisure time

hotspot

focus

Novavax promises a turnaround & Lilly roils the obesity market

What Congress can do to address the rural doctor shortage

United colonoscopy coverage change 'may cost lives,' doctors say

Unique patient identifier: Experts argue the benefits, pitfalls

Alkermes shareholders re

How AI helped researchers track recovery from depression

Drug repurposing or repositioning? The language matters

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

In Memoriam: Notable people who died in 2023

Johnson & Johnson sued for allegedly overpaying for workers' drugs

hotspot

Top private equity targets in 2023: cardiology, clinical trials, lasers

Padmanee Sharma of MD Anderson at center of lawsuit over credit

What Congress can do to address the rural doctor shortage

Biotech lab space demand falls sharply

What Congress can do to address the rural doctor shortage

How Vertex's cystic fibrosis drug is changing patients' lives

knowledge

entertainment

entertainment

knowledge